Ohyashiki, J. H., Ohtsuki, K., Mizoguchi, I., Yoshimoto, T., Katagiri, S., Umezu, T., & Ohyashiki, K. (2014). Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: A possible biomarker to discontinue imatinib safely. Dove Medical Press.

Ohyashiki, Junko H., Kazushige Ohtsuki, Izuru Mizoguchi, Takayuki Yoshimoto, Seiichiro Katagiri, Tomohiro Umezu, and Kazuma Ohyashiki. Downregulated MicroRNA-148b in Circulating PBMCs in Chronic Myeloid Leukemia Patients With Undetectable Minimal Residual Disease: A Possible Biomarker to Discontinue Imatinib Safely. Dove Medical Press, 2014.

Ohyashiki, Junko H., et al. Downregulated MicroRNA-148b in Circulating PBMCs in Chronic Myeloid Leukemia Patients With Undetectable Minimal Residual Disease: A Possible Biomarker to Discontinue Imatinib Safely. Dove Medical Press, 2014.